INVEGA 3 MG EXTENDED RELEASE 28 TABLETS

INVEGA 3 MG EXTENDED RELEASE 28 TABLETS offer a crucial treatment option for individuals managing the complex conditions of schizophrenia and schizoaffective disorder. Developed by Janssen Pharmaceuticals, this medication is designed to provide consistent symptom control with the convenience of once-daily dosing.

This product can typically be found on leading pharmaceutical e-commerce platforms like Nahdi Online and , where customers can explore its details and availability.

Product Details

• Brand: Invega
• Manufacturer: Janssen Pharmaceuticals (part of Johnson & Johnson)
• Active Ingredient: Paliperidone
• Strength: 3 MG
• Dosage Form: Extended Release Tablets
• Package Size: 28 Tablets

Benefits of Use

INVEGA 3 MG EXTENDED RELEASE TABLETS are specifically formulated to help manage the symptoms of schizophrenia and schizoaffective disorder, offering several key benefits:

• Effective in reducing positive symptoms (e.g., hallucinations, delusions) and negative symptoms (e.g., apathy, social withdrawal) associated with schizophrenia.
• Provides stable and consistent medication levels throughout the day due to its extended-release formulation.
• Offers the convenience of once-daily dosing, which can improve adherence to treatment regimens.
• Helps in maintaining mental stability and improving overall quality of life for patients.
• Part of a comprehensive treatment plan to support long-term psychiatric management.

How to Use

Always take INVEGA 3 MG EXTENDED RELEASE TABLETS exactly as prescribed by your healthcare professional. Do not exceed the recommended dose.

1. Take one tablet orally, once daily, typically in the morning.
2. Swallow the tablet whole with water. Do not chew, crush, or break the tablet, as this can affect the extended-release mechanism and lead to an overdose.
3. INVEGA can be taken with or without food. However, it should be taken consistently either with food or without food, but not inconsistently, to ensure steady absorption.
4. Continue taking this medication regularly, even if you feel well, as stopping abruptly can lead to a return of symptoms.
5. If you miss a dose, take it as soon as you remember, unless it is almost time for your next dose. Do not take two doses at once to make up for a missed dose.

Caution & Warnings

• Prescription Only: This is a prescription medication. Do not use without consulting a doctor.
• Drowsiness/Dizziness: May cause drowsiness or dizziness, especially at the start of treatment. Avoid driving or operating heavy machinery until you know how it affects you.
• Elderly Patients with Dementia-Related Psychosis: INVEGA is not approved for the treatment of patients with dementia-related psychosis and increases the risk of death in elderly patients with this condition.
• Neuroleptic Malignant Syndrome (NMS): A potentially fatal condition that can occur with antipsychotic medications. Seek immediate medical attention if you experience fever, muscle rigidity, altered mental status, or autonomic instability.
• Tardive Dyskinesia (TD): Involuntary movements, primarily of the face and tongue, can develop. If this occurs, consult your doctor.
• Metabolic Changes: Atypical antipsychotics, including Invega, have been associated with metabolic changes such as hyperglycemia, diabetes mellitus, dyslipidemia, and weight gain. Regular monitoring is recommended.
• Orthostatic Hypotension: May cause a drop in blood pressure upon standing, leading to dizziness or fainting. Use caution when rising from a sitting or lying position.
• Drug Interactions: Inform your doctor about all other medications you are taking, including over-the-counter drugs, supplements, and herbal remedies, to avoid potential interactions.
• Pregnancy and Breastfeeding: Consult your doctor if you are pregnant, planning to become pregnant, or breastfeeding.
• Suicidal Thoughts: Patients, especially children, adolescents, and young adults, taking antidepressants (which includes some antipsychotics for mood stabilization) for major depressive disorder and other psychiatric disorders may experience an increase in suicidal thoughts or actions. Close monitoring is advised.

Ingredients

• Active Ingredient: Paliperidone 3 mg
• Inactive Ingredients: May vary by formulation but commonly include polyethylene glycol, carnauba wax, hydroxypropyl methylcellulose, magnesium stearate, titanium dioxide, and iron oxides (e.g., yellow and/or red) for coloring. Consult the package leaflet for the exact list.